Researcher
Dominiek Smeets
- Disciplines:Morphological sciences, Oncology
Affiliations
- Laboratory of Translational Genetics (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → 11 Feb 2020
Projects
1 - 1 of 1
- Tumor heterogeneity in relapsed or metastatic breast, ovarian and colorectal cancerFrom10 Oct 2011 → 6 Nov 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 24
- Tumor heterogeneity in relapsed or metastatic breast, ovarian and colorectal cancer(2019)
Authors: Dominiek Smeets, Diether Lambrechts
- Ischemia-Induced DNA Hypermethylation during Kidney Transplant Predicts Chronic Allograft Injury(2018)
Authors: Line Heylen, Bernard Thienpont, Maarten Naesens, Pieter Busschaert, Dominiek Smeets, Ina Jochmans, Diethard Monbaliu, Jacques Pirenne, Evelyne Lerut, Dirk Kuypers, et al.
Pages: 1566 - 1576 - Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach(2017)
Authors: Dominiek Smeets, Diether Lambrechts
Pages: 48126 - 48137 - Erratum: Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations(2017)
Authors: David Brown, Dominiek Smeets, Borbála Székely, Denis Larsimont, A Marcell Szász, Pierre-Yves Adnet, Françoise Rothé, Ghizlane Rouas, Zsófia I Nagy, Zsófia Faragó, et al.
Pages: 15759 - Chromosomal instability in cell-free DNA as a highly specific biomarker for detection of ovarian cancer in women with adnexal masses(2017)
Authors: Adriaan Vanderstichele, Pieter Busschaert, Dominiek Smeets, Chiara Landolfo, Els Van Nieuwenhuysen, Patrick Neven, Frédéric Amant, An Coosemans, Dirk Timmerman, Diether Lambrechts, et al.
Pages: 2223 - 2231 - Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations(2017)
Authors: Dominiek Smeets, Diether Lambrechts, Christine Desmedt
- Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching(2017)
Authors: Linde De Smedt, Olivier Govaere, Bram Boeckx, Dominiek Smeets, Eva Galle, Jasper Wouters, Jeroen Dekervel, Thomas Tousseyn, Gert De Hertogh, Hans Prenen, et al.
Pages: 58 - 65 - PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS(2016)
Authors: Els Wauters, Dominiek Smeets, Benoit Beuselinck, Beppe Floris, Diether Lambrechts, Els Van Nieuwenhuysen, Ignace Vergote
Pages: 800 - 811 - Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer (vol 53, pg 51, 2016)(2016)
Authors: Sandrina Lambrechts, Dominiek Smeets, Matthieu Moisse, Elena Ioana Braicu, Adriaan Vanderstichele, Hui Zhao, Els Van Nieuwenhuysen, Els Berns, Jalid Sehouli, Robert Zeillinger, et al.
Pages: 226 - 226 - No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer(2016)
Authors: Diether Lambrechts, Sandrina Lambrechts, Patrick Neven, Benoit Beuselinck, Dominiek Smeets, Els Van Nieuwenhuysen, Ignace Vergote, Caroline Weltens
Pages: 386 - 401
Patents
1 - 2 of 2
- Means and methods for anti-vegf therapy (Inventor)
- Means and methods for anti-vegf therapy (Inventor)